Tag Archives | Harold Selick

PDL BioPharma

PDL BioPharma: Proxy Score 40

PDL BioPharma Inc (NASD:PDLI), one of the stocks in my portfolio, manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Their annual meeting is coming up […]

Continue Reading ·

Powered by WordPress. Designed by WooThemes